Abstract
Adult T-cell leukemia (ATL) develops in carriers of human T-cell leukemia virus (HTLV-1) in adulthood after a long period of clinical latency. Epidemiological data have demonstrated that leukemogenesis is based on a multistep carcinogenesis model involving five or more genetic events. However, detailed genetic and epigenetic events that lead to the transformation of HTLV-1-infected cells have not yet been clarified. This chapter summarizes the current knowledge on the clonal growth of HTLV-1-infected cells, including ATL cells in vivo, gene expression profiles, and genetic and epigenetic events characterized to date. HTLV-1-infected T cells immortalized by HTLV-1 have been shown to result in polyclonal growth in vivo, with over 10,000 clones. ATL cells usually arise from one specific clone; however, occasional concurrent transformation can result in ATL with multiple clones. A multicolor fluorescence-activated cell sorting (FACS) system developed to identify and sort HTLV-1-infected CD4+ T cells enabled the characterization of cellular and genetic/epigenetic changes during malignant transformation in vivo. Next-generation sequencing (NGS) techniques have led to studies that provide a comprehensive landscape of genetic abnormalities in ATL cells. Revelation of the epigenetic landscape of ATL cells, combined with genetic information, provided the basis for understanding abnormalities in the transcriptome of ATL cells. This new set of information advanced our understanding of leukemogenesis and provided the basis for drug development, although mechanisms underlying the progressive accumulation of these abnormalities remain to be clarified.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1997;50:481–92.
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77:7415–9.
Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984–87). Br J Haematol. 1991;79:428–39.
Okamoto T, Ohno Y, Tsugane S, et al. Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res. 1989;80:191–5.
Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A. 1984;81:2534–7.
Yamaguchi K, Seiki M, Yoshida M, Nishimura H, Kawano F, Takatsuki K. The detection of human T cell leukemia virus proviral DNA and its application for classification and diagnosis of T cell malignancy. Blood. 1984;63:1235–40.
Kondo S, Kotani T, Tsumori S, et al. Identification of biclonal (duplex) leukemia cells expressing CD4+/CD8- or CD4−/CD8+ from a patient with adult T-cell leukemia/lymphoma. Br J Haematol. 1995;89:669–71.
Shibata K, Shimamoto Y, Suga K, et al. Adult T-cell leukemia/lymphoma with two distinct clones in peripheral blood and lymph node. Am J Hematol. 1995;48:116–9.
Shimamoto Y, Kikuchi M, Funai N, Suga K, Matsuzaki M, Yamaguchi M. Spontaneous remission in adult T-cell leukemia/lymphoma. Cancer. 1993;72:735–40.
Kato N, Sugawara H, Aoyagi S, Mayuzumi M. Lymphoma-type adult T-cell leukemia-lymphoma with a bulky cutaneous tumor showing multiple human T-lymphotropic virus-1 DNA integration. Br J Haematol. 2001;144:1244–8.
Tsukasaki K, Tsushima H, Yamamura M, et al. Integration patterns of HTLV-1 provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood. 1997;89:948–56.
Umino A, Nakagawa M, Utsunomiya A, Tsukasaki K, Taira N, Katayama N, Seto M. Clonal evolution of adult T-cell leukemia/lymphoma takes place in the lymph nodes. Blood. 2011;117:5473–8. doi:10.1182/blood-2010-12-327791.
Umino A, Seto M. Array CGH reveals clonal evolution of adult T-cell leukemia/lymphoma. Methods Mol Biol. 2013;973:189–96. doi:10.1007/978-1-62703-281-0_12.
Takemoto S, Matsuoka M, Yamaguchi K, Takatsuki K. A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction. Blood. 1994;84:3080–5.
Etoh K, Tamiya S, Yamaguchi K, Okayama A, Tsubouchi H, Ideta T, Mueller N, Takatsuki K, Matsuoka M. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res. 1997;57:4862–7.
Ohshima K, Mukai Y, Shiraki H, Suzumiya J, Tashiro K, Kikuchi M. Clonal integration and expression of human T-cell lymphotropic virus type I in carriers detected by polymerase chain reaction and inverse PCR. Am J Hematol. 1997;54:306–12.
Eiraku N, Hingorani R, Ijichi S, et al. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. J Immunol. 1998;161:6674–80.
Okayama A, Stuver S, Iga M, et al. Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I. J Infect Dis. 2001;183:1031–107.
Tanaka G, Okayama A, Watanabe T, et al. The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J Infect Dis. 2005;191:1140–7.
Cavrois M, Wain-Hobson S, Wattel E. Stochastic events in the amplification of HTLV-I integration sites by linker-mediated PCR. Res Virol. 1995;146:179–84.
Cavrois M, Gessain A, Wain-Hobson S, Wattel E. Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. Oncogene. 1996;12:2419–23.
Gabet AS, Mortreux F, Talarmin A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene. 2000;19:4954–60.
Gillet NA, Malani N, Melamed A, et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood. 2011;117:3113–22. doi:10.1182/blood-2010-10-312926.
Melamed A, Laydon DJ, Gillet NA, Tanaka Y, Taylor GP, Bangham CR. Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog. 2013;9:e1003271. doi:10.1371/journal.ppat.1003271.
Cook LB, Melamed A, Niederer H, et al. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. Blood. 2014;123:3925–31. doi:10.1182/blood-2014-02-553602.
Firouzi S, López Y, Suzuki Y, Nakai K, Sugano S, Yamochi T, Watanabe T. Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med. 2014;6:46. doi:10.1186/gm568. eCollection 2014
Kobayashi S, Nakano K, Watanabe E, et al. CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-1-infected cells in adult T-cell leukemia/lymphoma. Clin Cancer Res. 2014;20:2851–61. doi:10.1158/1078-0432.CCR-13-3169.
Kobayashi S, Watanabe E, Ishigaki T, et al. Advanced HTLV-1 carriers and early-stage indolent ATLs are indistinguishable based on CADM1 positivity in flow cytometry. Cancer Sci. 2015;106:598–603. doi:10.1111/cas.12639.
Rosenblatt JD, Miles S, Gasson JC, Prager D. Transactivation of cellular genes by human retroviruses. Curr Top Microbiol Immunol. 1995;193:25–49.
Bertini R, Luini W, Sozzani S, et al. Identification of MIP-1 alpha/LD78 as a monocyte chemoattractant released by the HTLV-1-transformed cell line MT-4. AIDS Res Hum Retrovir. 1995;11:155–60.
Baba M, Imai T, Yoshida T, Yoshie O. Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type 1: role of the viral transactivator Tax. Int J Cancer. 1996;66:124–9.
Hasegawa H, Nomura T, Kohno M, et al. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood. 2000;95:30–8.
Yoshie O, Fujisawa R, Nakayama T, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood. 2002;99:1505–11.
Kuramochi M, Fukuhara H, Nobukuni T, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet. 2001;27:427–30.
Sasaki H, Nishikata I, Shiraga T, et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood. 2005;105:1204–13.
Watanabe T, Yamaguchi K, Takatsuki K, Osame M, Yoshida M. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene. J Exp Med. 1990;172:759–65.
Ishikawa T, Imura A, Tanaka K, et al. E-selectin and vascular cell adhesion molecule-1 mediate adult T-cell leukemia cell adhesion to endothelial cells. Blood. 1992;82:1590–8.
Imura A, Hori T, Imada K, et al. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med. 1996;183:2185–95.
Tatewaki M, Yamaguchi K, Matsuoka M, et al. Constitutive overexpression of the L-selectin gene in fresh leukemic cells of adult T-cell leukemia that can be transactivated by human T-cell lymphotropic virus type 1 Tax. Blood. 1995;86:3109–17.
Uchiyama T, Ishikawa T, Imura A. Cell adhesion molecules in HTLV-I infection. J AIDS Hum Retrovirol. 1996;13(Suppl 1):S114–8.
Koizumi S, Iwanaga M, Imai S, et al. Expression of myeloid cell phenotypes by a novel adult T-cell leukemia/lymphoma cell line. J Natl Cancer Inst. 1992;84:690–3.
Tricarico M, Macchi B, D'Atri S, Morrone S, Bonmassar E, Fuggetta MP, Graziani G. In vitro infection of CD4+ T lymphocytes with HTLV-1 generates immortalized cell lines coexpressing lymphoid and myeloid cell markers. Leukemia. 1999;13:222–9.
Pichler K, Schneider G, Grassmann R. Microrna mir-146a and further oncogenesis-related cellular micrornas are dysregulated in HTLV-1-transformed T lymphocytes. Retrovirology. 2008;5:e100.
Bellon M, Lepelletier Y, Hermine O, Nicot C. Deregulation of microrna involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood. 2009;113:4914–7.
Yeung ML, Yasunaga J, Bennasser Y, et al. Roles for micrornas, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res. 2008;68:8976–85.
Yamagishi M, Nakano K, Miyake A, et al. Polycomb-mediated loss of miR-31 activates nik-dependent NF- κb pathway in adult T cell leukemia and other cancers. Cancer Cell. 2012;21:121–35.
Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, Yamamoto N. Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells. Blood. 1999;93:2360–8.
Watanabe M, Ohsugi T, Shoda M, et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood. 2005;106:2462–71.
Fukuda R, Hayashi A, Utsunomiya A, et al. Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL). Proc Natl Acad Sci U S A. 2005;102:15213–8.
Takemoto S, Mulloy JC, Cereseto A, et al. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci U S A. 1997;94:13897–902.
Kamada N, Sakurai M, Miyamoto K, et al. Chromosome abnormalities in adult T-cell leukemia/lymphoma: a karyotype review committee report. Cancer Res. 1992;52:1481–93.
Itoyama T, Chaganti RS, Yamada Y, et al. Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki. Blood. 2001;97:3612–20.
Tsukasaki K, Krebs J, Nagai K, Tomonaga M, Koeffler HP, Bartram CR, Jauch A. Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood. 2001;97:3875–81.
Sakashita A, Hattori T, Miller CW, et al. Mutations of the p53 gene in adult T-cell leukemia. Blood. 1992;79:477–80.
Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood. 1992;80:3205–16.
Nagai H, Kinoshita T, Imamura J, et al. Genetic alteration of p53 in some patients with adult T-cell leukemia. Jpn J Cancer Res. 1991;82:1421–7.
Tawara M, Hogerzeil SJ, Yamada Y, et al. Impact of p53 aberration on the progression of adult T-cell leukemia/lymphoma. Cancer Lett. 2006;234:249–55.
Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 1991;88:5413–7.
Yamato K, Oka T, Hiroi M, et al. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV- I-infected cells. Jpn J Cancer Res. 1993;84:4–8.
Reid RL, Lindholm PF, Mireskandari A, Dittmer J, Brady JN. Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. Oncogene. 1993;8:3029–36.
Takemoto S, Trovato R, Cereseto A, et al. p53 Stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(APF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells. Blood. 2000;95:3939–44.
Akagi T, Ono H, Tsuchida N, Shimotohno K. Aberrant expression and function of p53 in T cells immortalized by HTLV-I Tax1. FEBS Lett. 1997;406:263–6.
Pise-Masison CA, Choi K-S, Radonovich M, Dittmer J, Kim S-J, Brady JN. Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein. J Virol. 1998;72:1165–70.
Pise-Masison CA, Mahieux R, Jiang H, et al. Inactivation of p53 by human T-cell lymphotropic virus type 1 tax requires activation of the NF-κB pathway and is dependent on p53 phosphorylation. Mol Cell Biol. 2000;20:3377–86.
Mulloy JC, Kislyakova T, Cereseto A, et al. Human T-cell lymphotropic/leukemia virus type 1 tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J Virol. 1998;72:8852–60.
Pise-Masison CA, Mahieux R, Radonovich M, Jiang H, Brady JN. Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type- dependent. J Biol Chem. 2001;276:200–5.
Kataoka K, Nagata Y, Kitanaka A, et al. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet. 2015;47:1304–15. doi:10.1038/ng.3415.
Sherr CJ. Principles of tumor suppression. Cell. 2004;116:235–46.
Williams RT, Sherr CJ. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL -induced leukemias. Cold Spring Harb Symp Quant Biol. 2008;73:461–7.
Trovato R, Cereseto A, Takemoto S, et al. Deletion of the p164A gene in ex vivo acute adult T cell lymphoma/leukemia cells and methylation of the p164A promoter in HTLV type I-infected T cell lines. AIDS Res Hum Retrovir. 2000;16:709–13.
Uchida T, Kinoshita T, Murate T, Saito H, Hotta T. CDKN2 (MTS1/p164) gene alterations in adult T-cell leukemia/lymphoma. Leuk Lymphoma. 1998;29:27–35.
Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP. Homozygous deletions of the p15 (MTS2) and p16 (CDKN2/MTS1) genes in adult T-cell leukemia. Blood. 1995;85:2699–704.
Watanabe M, Nakahata S, Hamasaki M, et al. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1- infected cell lines. J Virol. 2010;84:6966–77.
Hatta Y, Yamada Y, Tomonaga M, Koeffler HP. Extensive analysis of the retinoblastoma gene in adult T cell leukemia/lymphoma (ATL). Leukemia. 1997;11:984–9.
Takeuchi S, Takeuchi N, Tsukasaki K, et al. Mutations in the retinoblastoma-related gene RB2/p130 in adult T-cell leukaemia/lymphoma. Leuk Lymphoma. 2003;44:699–701.
Hangaishi A, Ogawa S, Imamura N, et al. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood. 1996;87:4949–58.
Nakayama K, Yamada Y, Koji T, Hayashi T, Tomonaga M, Kamihira S. Expression and phosphorylation status of retinoblastoma protein in adult T-cell leukemia/lymphoma. Leuk Res. 2000;24:299–305.
Krystal G, Damen JE, Helgason CD, et al. SHIPs ahoy. Int J Biochem Cell Biol. 1999;31:1007–10.
Sato H, Oka T, Shinnou Y, et al. Multi-step aberrant CpG island hyper-methylation is associated with the progression of adult T-cell leukemia/lymphoma. Am J Pathol. 2010;176:402–15.
Nakahata S, Morishita K. CADM1/TSLC1 is a novel cell surface marker for adult T-cell leukemia/lymphoma. J Clin Exp Hematopathol. 2012;52(1):17–22.
Asanuma S, Yamagishi M, Kawanami K, et al. Adult T-cell leukemia cells are characterized by abnormalities of Helios expression that promotes T-cell growth. Cancer Sci. 2013;104:1097–106. doi:10.1111/cas.12181.
Kataoka K, Shiraishi Y, Takeda Y, et al. Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers. Nature. 2016; doi:10.1038/nature18294.
Nagata Y, Kontani K, Enami T, et al. Variegated RHOA mutations in adult T-cell leukemia/lymphoma. Blood. 2016;127:596–604. doi:10.1182/blood-2015-06-644948.
Yeh CH, Bai XT, Moles R, Ratner L, Waldmann TA, Watanabe T, Nicot C. Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia. Mol Cancer. 2016;15:15. doi:10.1186/s12943-016-0500-z.
Nosaka K, Maeda M, Tamiya S, et al. Increasing methylation of the CDKN2A gene is associated with the progression of adult T-cell leukemia. Cancer Res. 2000;60:1043–8.
Hofmann WK, Tsukasaki K, Takeuchi N, et al. Methylation analysis of cell cycle control genes in adult T-cell leukemia/lymphoma. Leuk Lymphoma. 2001;42:1107–9.
Taniguchi A, Nemoto Y, Yokoyama A, Kotani N, Imai S, Shuin T, Daibata M. Promoter methylation of the bone morphogenetic protein-6 gene in association with adult T-cell leukemia. Int J Cancer. 2008;123:1824–31. doi:10.1002/ijc.23749.
Yang Y, Takeuchi S, Tsukasaki K, et al. Methylation analysis of the adenomatous polyposis coli (APC) gene in adult T-cell leukemia/lymphoma. Leuk Res. 2005;29:47–51.
Tsuji T, Sugahara K, Tsuruda K, et al. Clinical and oncologic implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells. Int J Hematol. 2004;80:254–60.
Yasunaga J, Taniguchi Y, Nosaka K, et al. Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res. 2004;64:6002–9.
Yoshida M, Nosaka K, Yasunaga J, et al. Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood. 2004;103:2753–60.
Nishioka C, Ikezoe T, Yang J, et al. Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappa B. Leuk Res. 2008;32:287–96.
Chiechio S, Zammataro M, Morales ME, et al. Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain. Mol Pharmacol. 2009;75:1014–20.
Ahsan MK, Masutani H, Yamaguchi Y, et al. Loss of interleukin-2-dependency in HTLV-I -infected T cells on gene silencing of thioredoxin-binding protein-2. Oncogene. 2006;25:2181–91.
Nishinaka Y, Nishiyama A, Masutani H, et al. Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res. 2004;64:1287–92.
Zimmerman B, Sargeant A, Landes K, Fernandez SA, Chen CS, Lairmore MD. Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma. Leuk Res. 2011;35:1491–7.
Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer. 2006;6:846–56.
Fujikawa D, Nakagawa S, Hori M, et al. Polycomb-dependent epigenetic landscape in adult T-cell leukemia. Blood. 2016;127:1790–802. doi:10.1182/blood-2015-08-662593.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Japan KK
About this chapter
Cite this chapter
Watanabe, T. (2017). Leukemogenesis and Molecular Characteristics of Tumor Cells. In: Watanabe, T., Fukushima, T. (eds) Adult T-cell Leukemia/Lymphoma. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56523-9_6
Download citation
DOI: https://doi.org/10.1007/978-4-431-56523-9_6
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56521-5
Online ISBN: 978-4-431-56523-9
eBook Packages: MedicineMedicine (R0)